Dyschromatosis symmetrica hereditaria associated with neurological disorders

Journal of Dermatology

Volumn 35, Issue 10, 2008, Pages 662-666

  Kondo, Taisuke ^a   Suzuki, Tamio ^b   Ito, Shiro ^a   Kono, Michihiro ^a   Negoro, Tamiko ^a   Tomita, Yasushi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

Author keywords

Brain calcification; Dyschromatosis symmetrica hereditaria; Dystonia; Mental deterioration

Indexed keywords

ADENOSINE DEAMINASE; COMPLEMENTARY DNA; DNA;

ADAR1 GENE; ANAMNESIS; ARTICLE; BRAIN CALCIFICATION; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; DYSCHROMATOSIS SYMMETRICA HEREDITARIA; DYSTONIA; GENE; GENE MUTATION; GENODERMATOSIS; HUMAN; HYPOPIGMENTATION; LABORATORY TEST; MALE; MENTAL DETERIORATION; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; SCHOOL CHILD;

ADENOSINE DEAMINASE; BRAIN DISEASES; CHILD; DYSTONIA; HUMANS; MALE; MENTAL RETARDATION; MUTATION; PIGMENTATION DISORDERS;

EID: 54349085590     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2008.00540.x     Document Type: Article

References (28)

1. Toyama I. [An unknown disorder of hyperpigmentation.] Jpn J Dermatol Urol 1910 10 : 644. (In Japanese.)
2. Toyama I. [Dyschromatosis symmetrica hereditaria.] Jpn J Dermatol Urol 1929 27 : 95 96. (In Japanese.)
3. Miyamura Y, Suzuki T, Kono M et al. Mutations of the RNA-specific adenosine deaminase gene (DSRAD) are involved in dyschromatosis symmetrica hereditaria. Am J Hum Genet 2003 73 : 693 699.
4. Suzuki N, Suzuki T, Inagaki K et al. Mutation analysis of the ADAR1 gene in dyschromatosis symmetrica hereditaria and genetic differentiation from both dyschromatosis universalis hereditaria and acropigmentation reticularis. J Invest Dermatol 2005 124 : 1186 1192.
5. Suzuki N, Suzuki T, Inagaki K et al. The novel mutation analysis of the ADAR1 gene in Japanese patients with dyschromatosis symmetrica hereditaria. J Invest Dermatol 2007 127 : 309 311.
6. Liu Q, Liu W, Jiang L et al. Novel mutations of the RNA-specific adenosine deaminase gene (DSRAD) in Chinese families with dyschromatosis symmetrica hereditaria. J Invest Dermatol 2004 122 : 896 899.
7. Chao SC, Lee JY, Sheu HM, Yang MH. A novel deletion mutation of the DSRAD gene in a Taiwanese patient with dyschromatosis symmetrica hereditaria. Br J Dermatol 2005 153 : 1064 1066.
8. Liu Q, Jiang L, Liu WL et al. Two novel mutations and evidence for haploinsufficiency of the ADAR gene in dyschromatosis symmetrica hereditaria. Br J Dermatol 2006 154 : 636 642.
9. Chao SC, Huang CY, Yang MH. A novel mutation of the DSRAD gene in a Taiwanese family with dyschromatosis symmetrica hereditaria. Eur J Dermatol 2006 16 : 449 450.
10. Bass BL, Weintraub H. An unwinding activity that covalently modifies its double-stranded RNA substrate. Cell 1988 55 : 1089 1098.
11. Melcher T, Mass S, Herb A et al. A mammalian RNA editing enzyme. Nature 1996 379 : 460 464.
12. Tojo K, Sekijima Y, Suzuki T et al. Dystonia, mental deterioration, and dyschromatosis symmetrica hereditaria in family with ADAR1 mutation. J Mov Disord 2006 21 : 1510 1513.
13. Patrizi A, Manneschi V, Pini A et al. Dyschromatosis symmetrica hereditaria associated with idiopathic torsion dystonia. Acta Derm Venereol (Stockh). 1994 74 : 135 137.
14. Siemens HW. Acromelanosis albo-puncta. Dermatologica 1964 128 : 86 87.
15. Gharpuray MB, Tolat SN, Patwardham SP. Dyschromatosis: its occurrence in two Indian families with unusual features. Int J Dermatol 1994 33 : 391 392.
16. Rueter SM, Dawson TR, Emeson RB. Regulation of alternative splicing by RNA editing. Nature 1999 399 : 75 80.
17. Kim U, Wang Y, Sanford T et al. Molecular cloning of cDNA for double-stranded RNA adenosine deamnase, a candidate enzyme for nuclear RNA editing. Proc Natl Acad Sci USA 1994 91 : 11457 11461.
18. Higuchi M, Single FN, Kohler M et al. RNA editing of AMPA receptor subunit GluR-B: a base-paired intron-exon structure determines position and efficiency. Cell. 1993 75 : 1361 1370.
19. Lomeli H, Mosbacher J, Melcher T et al. Control of kinetic properties of AMPA receptor channels by nuclear RNA editing. Science 1994 266 : 1709 1713.
20. Burns CM, Chu H, Rueter SM et al. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 1997 387 : 303 308.
21. Polson AG, Bass BL, Casey JL. RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase. Nature 1996 380 : 454 456.
22. Bischoff S, Barhanin J, Bettler B et al. Spatial distribution of kainate receptor subunit mRNA in the mouse basal ganglia and ventral mesencephalon. J Comp Neurol 1997 379 : 541 562
23. Nobrega JN, Raymond R, Barlow K et al. Changes in AMPA receptor binding in an animal model of inborn paroxysmal dystonia. Exp Neurol 2002 176 : 371 376.
24. Richer A, Loscher W, Loschmann PA. The AMPA receptor antagonist NBQX exerts antidystonic effects in an animal model of idiopathic dystonia. Eur J Pharmacol 1993 231 : 287 291.
25. Wang Q, Khllian J, Gaude P et al. Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis. Science 2000 290 : 1765 1768.
26. Kwak S, Kawahara Y. Deficient RNA editing of GluR2 and neuronal death in amyotrophic lateral sclerosis. J Mol Med 2005 83 : 110 120.
27. Kim KM, Herrera GA, Battarbee HD. Role of glutaraldehyde in calcification of porcine aortic valve fibroblasts. Am J Pathol 1999 154 : 843 852.
28. Manyam BV, Walters AS, Narla KR. Bilateral striopallidodentate calcinosis: clinical characteristics of patients seen in a registry. Mov Disord 2001 16 : 258 264.